Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park I.-S. | - |
dc.contributor.author | 김성찬 | - |
dc.contributor.author | Yim Yeajee | - |
dc.contributor.author | Park Ginam | - |
dc.contributor.author | Choi Jinahn | - |
dc.contributor.author | Won Cheolhee | - |
dc.contributor.author | Min Dal-Hee | - |
dc.date.accessioned | 2024-01-12T03:00:35Z | - |
dc.date.available | 2024-01-12T03:00:35Z | - |
dc.date.created | 2022-09-23 | - |
dc.date.issued | 2022-08 | - |
dc.identifier.issn | 2041-1723 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/76633 | - |
dc.description.abstract | Artificial, synthetic chaperones have attracted much attention in biomedical research due to their ability to control the folding of proteins and peptides. Here, we report bio-inspired multifunctional porous nanoparticles to modulate proper folding and intracellular delivery of therapeutic α-helical peptide. The Synthetic Nano-Chaperone for Peptide (SNCP) based on porous nanoparticles provides an internal hydrophobic environment which contributes in stabilizing secondary structure of encapsulated α-helical peptides due to the hydrophobic internal environments. In addition, SNCP with optimized inner surface modification not only improves thermal stability for α-helical peptide but also supports the peptide stapling methods in situ, serving as a nanoreactor. Then, SNCP subsequently delivers the stabilized therapeutic α-helical peptides into cancer cells, resulting in high therapeutic efficacy. SNCP improves cellular uptake and bioavailability of the anti-cancer peptide, so the cancer growth is effectively inhibited in vivo. These data indicate that the bio-inspired SNCP system combining nanoreactor and delivery carrier could provide a strategy to expedite the development of peptide therapeutics by overcoming existing drawbacks of α-helical peptides as drug candidates. | - |
dc.language | English | - |
dc.publisher | Nature Publishing Group | - |
dc.title | Multifunctional synthetic nano-chaperone for peptide folding and intracellular delivery | - |
dc.type | Article | - |
dc.identifier.doi | 10.1038/s41467-022-32268-2 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Nature Communications, v.13, no.1 | - |
dc.citation.title | Nature Communications | - |
dc.citation.volume | 13 | - |
dc.citation.number | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000836609800003 | - |
dc.identifier.scopusid | 2-s2.0-85135598603 | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | MESOPOROUS SILICA NANOPARTICLES | - |
dc.subject.keywordPlus | PROTEIN SECONDARY STRUCTURE | - |
dc.subject.keywordPlus | ARTIFICIAL CHAPERONES | - |
dc.subject.keywordPlus | MOLECULAR CHAPERONES | - |
dc.subject.keywordPlus | P53 | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | TARGET | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.